Sam Riedijk

Dr. Sam Riedijk is an Associate Professor in the Department of Clinical Genetics at Erasmus MC, where he conducts research at the intersection of genomics, ethics, and public policy. His work emphasizes public engagement, decision-making, and the societal implications of human germline gene editing.

Research Interests: His primary research areas include human germline gene editing, genetic counseling, genomics, public and stakeholder engagement, ethical decision-making, and policy development. His fingerprint reveals strong activity in Germline, Germ Cell, Genome Editing, Exome Sequencing, and Coping Behavior, reflecting a transdisciplinary approach to clinical genetics and bioethics.

Publication Trends: Over the past few years, Dr. Riedijk has focused on the ethical and societal dimensions of gene editing, particularly the need for structured public dialogues, goal specification, and inclusive policy-making. His recent publications highlight a shift toward participatory models in science governance and the importance of patient and public perspectives in shaping genetic technologies.

Scientific Awards:

• No awards listed in the provided text.

Advising and Grants: Dr. Riedijk has supervised at least one doctoral thesis, indicating an active role in mentoring. He is involved in collaborative research through the DNA Dialogues Consortium, suggesting participation in funded, multi-institutional projects focused on public engagement in genetics. While specific grants are not listed, his frequent co-authorship in high-impact journals indicates sustained research funding.

Labs and Teams: He is affiliated with the DNA Dialogues Consortium, a transdisciplinary team dedicated to public engagement on genetic technologies. This consortium brings together experts from clinical genetics, ethics, social sciences, and policy to facilitate democratic dialogue on genome editing.